The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation

Warfarin is used as anticoagulant and Compound Danshen prescription (CDP) is able to promote blood circulation. The combination might produce a synergic effect for patients of coronary heart diseases (CHDs) with atrial fibrillation (AF). Whether the combination increases the bleeding risk of warfari...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Chunxiao, Liu, Changxiao, Yao, Zhuhua, Gao, Xiumei, Sun, Lanjun, Liu, Jia, Song, Haibo, Li, Ziqiang, Du, Xi, Sun, Jinxia, Li, Yanfen, Ye, Kui, Wang, Ruihua, Huang, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702344/
https://www.ncbi.nlm.nih.gov/pubmed/29209208
http://dx.doi.org/10.3389/fphar.2017.00826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702344/
https://www.ncbi.nlm.nih.gov/pubmed/29209208
http://dx.doi.org/10.3389/fphar.2017.00826

Ejemplares similares